Variant report

Variant	nsv562774
Chromosome Location	chr13:95951593-96027507
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1168)
CpG islands
(count:732)
Chromatin interactive
region (count:12)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1168 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr13:95966627-95967073	HepG2	liver:	n/a	n/a
2	ARID3A	chr13:95953876-95953898	HepG2	liver:	n/a	n/a
3	ARID3A	chr13:95953613-95953696	K562	blood:	n/a	n/a
4	ARID3A	chr13:95966752-95966960	K562	blood:	n/a	n/a
5	ARID3A	chr13:95952888-95953170	K562	blood:	n/a	n/a
6	ARID3A	chr13:95954220-95954222	K562	blood:	n/a	n/a
7	ARID3A	chr13:95969693-95970101	K562	blood:	n/a	n/a
8	ATF2	chr13:95953752-95954132	GM12878	blood:	n/a	n/a
9	BACH1	chr13:96001635-96001886	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr13:95953247-95954203	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr13:95969790-95969856	K562	blood:	n/a	n/a
12	BCLAF1	chr13:95952941-95953394	GM12878	blood:	n/a	n/a
13	BCLAF1	chr13:95953476-95954069	GM12878	blood:	n/a	chr13:95953785-95953794 chr13:95953720-95953733 chr13:95953620-95953633
14	BCLAF1	chr13:95951836-95952208	GM12878	blood:	n/a	chr13:95952082-95952091
15	BHLHE40	chr13:96012862-96013164	K562	blood:	n/a	n/a
16	BHLHE40	chr13:95951472-95951807	GM12878	blood:	n/a	n/a
17	BHLHE40	chr13:95953007-95954599	K562	blood:	n/a	chr13:95953784-95953800 chr13:95953446-95953462 chr13:95953443-95953459
18	BHLHE40	chr13:95953400-95954315	HepG2	liver:	n/a	chr13:95953784-95953800 chr13:95953446-95953462 chr13:95953443-95953459
19	BHLHE40	chr13:95969437-95969892	K562	blood:	n/a	n/a
20	BHLHE40	chr13:95953022-95954602	GM12878	blood:	n/a	chr13:95953784-95953800 chr13:95953446-95953462 chr13:95953443-95953459
21	BHLHE40	chr13:95966774-95966999	K562	blood:	n/a	n/a
22	BHLHE40	chr13:95954115-95954309	A549	lung:	n/a	n/a
23	BHLHE40	chr13:95951572-95951726	K562	blood:	n/a	n/a
24	BRCA1	chr13:95951787-95951795	Hela-S3	cervix:	n/a	n/a
25	BRCA1	chr13:95966541-95967031	Hela-S3	cervix:	n/a	n/a
26	BRCA1	chr13:95972005-95972368	Hela-S3	cervix:	n/a	n/a
27	BRCA1	chr13:95953565-95953620	HepG2	liver:	n/a	n/a
28	BRCA1	chr13:95955316-95955425	Hela-S3	cervix:	n/a	n/a
29	BRCA1	chr13:95953989-95954014	Hela-S3	cervix:	n/a	n/a
30	BRCA1	chr13:95952976-95953062	GM12878	blood:	n/a	n/a
31	CBX3	chr13:96015553-96015829	K562	blood:	n/a	n/a
32	CBX3	chr13:96008953-96009226	K562	blood:	n/a	n/a
33	CBX3	chr13:95953672-95954674	K562	blood:	n/a	n/a
34	CCNT2	chr13:95952980-95954262	K562	blood:	n/a	n/a
35	CCNT2	chr13:95969690-95969892	K562	blood:	n/a	n/a
36	CEBPB	chr13:95966626-95967127	Hela-S3	cervix:	n/a	n/a
37	CEBPB	chr13:95973519-95973677	HepG2	liver:	n/a	n/a
38	CEBPB	chr13:95966589-95967162	HCT-116	colon:	n/a	n/a
39	CEBPB	chr13:95953921-95954228	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr13:95966767-95966976	HepG2	liver:	n/a	n/a
41	CEBPB	chr13:95966710-95967200	MCF-7	breast:	n/a	n/a
42	CEBPB	chr13:96022472-96022715	IMR90	lung:	n/a	chr13:96022629-96022640
43	CEBPB	chr13:95966676-95967088	HepG2	liver:	n/a	n/a
44	CEBPB	chr13:96004765-96005063	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr13:95966696-95967048	HepG2	liver:	n/a	n/a
46	CEBPB	chr13:95969679-95969976	Hela-S3	cervix:	n/a	n/a
47	CEBPB	chr13:95966693-95967096	HepG2	liver:	n/a	n/a
48	CEBPB	chr13:95966667-95967172	MCF-7	breast:	n/a	n/a
49	CEBPB	chr13:95954091-95954583	GM12878	blood:	n/a	n/a
50	CEBPB	chr13:95957963-95958022	A549	lung:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:95952902-95952952	HIPEpiC	eye:	n/a
2	chr13:95953482-95953532	HRE	kidney:	n/a
3	chr13:96008021-96008071	HRPEpiC	eye:	n/a
4	chr13:95953574-95953624	SK-N-SH_RA	brain:	n/a
5	chr13:95953482-95953532	SKMC	muscle:	n/a
6	chr13:95954534-95954584	HIPEpiC	eye:	n/a
7	chr13:95953505-95953555	AG04450	lung:	fetal
8	chr13:95953482-95953532	A549	lung:	n/a
9	chr13:96008021-96008071	HCF	heart:	n/a
10	chr13:95954534-95954584	A549	lung:	n/a
11	chr13:95953505-95953555	NHDF-neo	bronchial:	n/a
12	chr13:95953574-95953624	MCF10A-Er-Src	breast:	n/a
13	chr13:95953941-95953991	Caco-2	colon:	n/a
14	chr13:95954534-95954584	MCF-7	breast:	n/a
15	chr13:95953505-95953555	Hepatocyte	liver:	n/a
16	chr13:95953574-95953624	A549	lung:	n/a
17	chr13:96008021-96008071	GM12878	blood:	n/a
18	chr13:95954534-95954584	AG09309	skin:	n/a
19	chr13:95953941-95953991	U87	brain:	n/a
20	chr13:95953574-95953624	NHDF-neo	bronchial:	n/a
21	chr13:95952937-95952987	NHDF-neo	bronchial:	n/a
22	chr13:95953941-95953991	AG10803	skin:	n/a
23	chr13:95953482-95953532	NT2-D1	testis:	n/a
24	chr13:95952937-95952987	GM12892	blood:	n/a
25	chr13:95953229-95953279	U87	brain:	n/a
26	chr13:95958190-95958240	IMR90	lung:	fetal
27	chr13:96008021-96008071	HNPCEpiC	eye:	n/a
28	chr13:96008021-96008071	PANC-1	pancreas:	n/a
29	chr13:95953574-95953624	LNCaP	prostate:	n/a
30	chr13:95954534-95954584	GM06990	blood:	n/a
31	chr13:95953941-95953991	HEEpiC	esophagus:	n/a
32	chr13:95953482-95953532	ProgFib	skin:	n/a
33	chr13:95952902-95952952	AG09319	gingival:	n/a
34	chr13:95952937-95952987	BE2_C	brain:	n/a
35	chr13:95953574-95953624	NB4	blood:	n/a
36	chr13:95953482-95953532	GM12878	blood:	n/a
37	chr13:95952902-95952952	SKMC	muscle:	n/a
38	chr13:95953229-95953279	GM12892	blood:	n/a
39	chr13:95952902-95952952	SK-N-SH	brain:	n/a
40	chr13:95952937-95952987	NT2-D1	testis:	n/a
41	chr13:95953941-95953991	MCF10A-Er-Src	breast:	n/a
42	chr13:95953229-95953279	HPAEpiC	pulmonary alveolar:	n/a
43	chr13:95952937-95952987	SK-N-SH_RA	brain:	n/a
44	chr13:96008021-96008071	HEEpiC	esophagus:	n/a
45	chr13:95953482-95953532	HAEpiC	amniotic membrane:	n/a
46	chr13:96008021-96008071	HIPEpiC	eye:	n/a
47	chr13:95953505-95953555	AG09309	skin:	n/a
48	chr13:95953941-95953991	AG09309	skin:	n/a
49	chr13:95954080-95954130	GM12878	blood:	n/a
50	chr13:95954382-95954432	SAEC	small airway:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:95952688..95955357-chr13:95971303..95973623,2	K562	blood:
2	chr13:60970248..60971090-chr13:95952535..95953452,2	Hela-S3	cervix:
3	chr13:95950632..95952981-chr13:95955199..95956850,2	K562	blood:
4	chr13:96010392..96012474-chr13:96022109..96025076,2	K562	blood:
5	chr13:96010392..96012474-chr13:96022109..96025076,2	K562	blood:
6	chr13:95889668..95892228-chr13:95954506..95956697,2	K562	blood:
7	chr13:95950632..95952981-chr13:95955199..95956850,2	K562	blood:
8	chr1:149223926..149224513-chr13:95953070..95953746,2	Hela-S3	cervix:
9	chr13:95990065..95992069-chr13:95994982..95997042,2	K562	blood:
10	chr13:95953151..95954875-chr13:95967251..95969604,2	K562	blood:
11	chr13:95953151..95954875-chr13:95967251..95970117,3	K562	blood:
12	chr13:95990065..95992069-chr13:95994982..95997042,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CLDN10-6	chr13:95957471-95958654	NONHSAT034755
2	lnc-ABCC4-1	chr13:95956351-95956401	XLOC_010696
3	lnc-ABCC4-2	chr13:96003796-96003967	NONHSAT034758
4	lnc-ABCC4-1	chr13:95954705-95955669	XLOC_010696

No data

Variant related genes	Relation type
RNY3P8	TF binding region
RNY4P27	TF binding region
ABCC4	TF binding region
RNY3P8	CpG island
RNY4P27	CpG island
ABCC4	CpG island
ENSG00000125257	chromatin interactions
ENSG00000083544	chromatin interactions
ENSG00000206737	chromatin interactions
SMAD4	miRNA target sites

Extended variants
information (count: 2802 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:2802 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17189561	chr13:95951593-95951594	Weak transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs567492945	chr13:95951598-95951599	Weak transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
3	rs115938387	chr13:95951680-95951681	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs191319807	chr13:95951698-95951699	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs536347304	chr13:95951717-95951718	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs145051303	chr13:95951718-95951719	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs534707157	chr13:95951729-95951730	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs571334502	chr13:95951742-95951743	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs377162306	chr13:95951817-95951818	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs578185205	chr13:95951818-95951819	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs201848023	chr13:95951819-95951820	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs115448721	chr13:95951844-95951845	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs142152338	chr13:95951878-95951879	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs548726662	chr13:95951900-95951901	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs181226173	chr13:95951908-95951909	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs11841955	chr13:95951945-95951946	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs559503509	chr13:95951967-95951968	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs370315945	chr13:95951972-95951973	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs565578347	chr13:95951995-95951996	Weak transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs114322190	chr13:95952041-95952042	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs9524894	chr13:95952079-95952080	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs564941405	chr13:95952081-95952082	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs530704612	chr13:95952082-95952083	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs537114349	chr13:95952111-95952112	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs560897105	chr13:95952113-95952114	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs529916057	chr13:95952159-95952160	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs9524895	chr13:95952161-95952162	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs567659636	chr13:95952181-95952182	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565840053	chr13:95952198-95952199	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs534838446	chr13:95952246-95952247	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs55667930	chr13:95952254-95952255	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs375850158	chr13:95952257-95952258	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs571650651	chr13:95952269-95952270	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs537325265	chr13:95952296-95952297	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs557660133	chr13:95952342-95952343	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs190652396	chr13:95952353-95952354	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs147059872	chr13:95952371-95952372	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs553054953	chr13:95952372-95952373	Weak transcription Active TSS Transcr. at gene 5' and 3' Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs572970330	chr13:95952429-95952430	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs8001444	chr13:95952437-95952438	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs202117755	chr13:95952472-95952473	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs374107212	chr13:95952473-95952474	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs375151694	chr13:95952478-95952479	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs369682987	chr13:95952479-95952480	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs373291980	chr13:95952480-95952481	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs117454266	chr13:95952553-95952554	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs35513103	chr13:95952591-95952592	Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Genic enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs4148420	chr13:95952630-95952631	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs200656138	chr13:95952631-95952632	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs544150850	chr13:95952633-95952634	Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	18632612	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Metanephric adenoma	20802469	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Rhabdomyosarcoma	17210683	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21183584	CNVD
Breast cancer	17603634	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thyroid cancer	19087340	CNVD
abortions and stillbirths	19751515	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute myeloid leukemia	19651601	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Burkitt''s lymphoma	20823134	CNVD

Chromatin state (count:751 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:95920200-95952800	Weak transcription	Aorta	Aorta
2	chr13:95924600-95952600	Weak transcription	Primary hematopoietic stem cells	blood
3	chr13:95926600-95952400	Weak transcription	Brain Hippocampus Middle	brain
4	chr13:95933000-95952600	Weak transcription	Primary T cells from cord blood	blood
5	chr13:95933400-95952600	Weak transcription	Fetal Stomach	stomach
6	chr13:95933800-95952400	Weak transcription	HSMM	muscle
7	chr13:95933800-95952400	Weak transcription	NHDF-Ad	bronchial
8	chr13:95934000-95951600	Weak transcription	Osteobl	bone
9	chr13:95938200-95952600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
10	chr13:95938800-95952400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr13:95940200-95952000	Weak transcription	Left Ventricle	heart
12	chr13:95941800-95952400	Weak transcription	Esophagus	oesophagus
13	chr13:95941800-95952400	Weak transcription	Pancreas	Pancrea
14	chr13:95943600-95952400	Weak transcription	Primary T cells fromperipheralblood	blood
15	chr13:95943800-95952400	Weak transcription	Brain Inferior Temporal Lobe	brain
16	chr13:95945600-95952400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
17	chr13:95946800-95951600	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr13:95947000-95952400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr13:95947600-95952400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr13:95948600-95952600	Enhancers	Fetal Intestine Large	intestine
21	chr13:95948800-95952800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
22	chr13:95949000-95952400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
23	chr13:95949000-95952600	Weak transcription	Gastric	stomach
24	chr13:95949000-95952600	Weak transcription	Psoas Muscle	Psoas
25	chr13:95949200-95951600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr13:95949200-95952200	Weak transcription	Colonic Mucosa	Colon
27	chr13:95949600-95952000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr13:95949600-95952400	Enhancers	Muscle Satellite Cultured Cells	--
29	chr13:95949800-95951600	Enhancers	Lung	lung
30	chr13:95949800-95952400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr13:95949800-95952400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr13:95950000-95952200	Weak transcription	Skeletal Muscle Female	skeletal muscle
33	chr13:95950000-95952400	Weak transcription	Brain Substantia Nigra	brain
34	chr13:95950000-95952400	Enhancers	Duodenum Mucosa	Duodenum
35	chr13:95950000-95952400	Weak transcription	Fetal Muscle Leg	muscle
36	chr13:95950000-95952600	Weak transcription	Fetal Kidney	kidney
37	chr13:95950200-95952400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr13:95950600-95951800	Enhancers	Skeletal Muscle Male	skeletal muscle
39	chr13:95950600-95951800	Flanking Active TSS	GM12878-XiMat	blood
40	chr13:95950600-95952000	Flanking Active TSS	A549	lung
41	chr13:95950600-95952400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr13:95950600-95954400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr13:95950800-95951800	Transcr. at gene 5' and 3'	K562	blood
44	chr13:95950800-95952200	Enhancers	Stomach Smooth Muscle	stomach
45	chr13:95950800-95952800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
46	chr13:95951000-95951600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
47	chr13:95951000-95951600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr13:95951000-95951800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
49	chr13:95951000-95951800	Weak transcription	Rectal Mucosa Donor 29	rectum
50	chr13:95951000-95952000	Enhancers	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links